BiliCalc

Name: BiliCalc
Price: 1.99 USD
Rating: 2.9 (27 reviews)
Author: Jacob Beniflah, MD

By: Jacob Beniflah, MD

Medical

Features & Capabilities

Designed by a pediatrician, BiliCalc uses the American Academy of Pediatrics 2004 "Management of Hyperbilirubinemia in Infants Greater than 35 Weeks of Age" to calculate the threshold for starting phototherapy based on the patient's age, bilirubin level, and neurotoxicity risk. Values are now displayed on the phototherapy nomogram. In addition, it will also tell you the patient's risk zone using the Bhutani Nomogram.

Allows direct age input and includes the option to calculate age from birth and lab sample times. The app has a direct link to source journal articles, nomograms, and a list of the neurotoxicity risk factors. Supports US and SI units (mg/dL and µmol/L).

App Feature Summary -Calculates phototherapy threshold for newborns 35 weeks and older -Displays values on phototherapy nomogram -Suggests time frame for followup bilirubin levels based on patient risk zone -Direct links to reference journal articles

Frequently Asked Questions

I think the graph is backwards. Why is low risk on top and high risk on bottom?

The graph is directly from the 2004 AAP Hyperbilirubinemia Guidelines. The degree of "risk" refers to the infant's risk for developing neurotoxicity. This is different than the Bhutani Nomogram in which "risk" refers to the risk for development of severe hyperbilirubinemia. The threshold for treatment (when a data point lies above one of the lines on the graph) of the infant is different based on the predisposing factors (divided into the three risk categories). Babies who are "low neurotoxicity risk," can tolerate higher levels of bilirubin than a baby with medium or high risk. Therefore, a high risk baby will be treated at lower bilirubin levels than a low risk baby. The graph is correct in having low risk on top since a higher value is needed to pass the threshold for treatment (phototherapy). Please see the graph here for verification as well: http://bit.ly/AppPWU. Please email if you have further questions.

Intended for use by pediatricians, neonatologists, physicians, medical students, and pediatric nurses who treat newborn infants in the hospital and as outpatients.

BiliCalc should be used only as a reference aid. The information contained in the app should not be used as a substitute for the exercise of professional clinical judgement. Please contact the developer if you find any errors.

Keywords: bilitool, bilitool.org, jaundice, hyperbiliubinemia

User Growth & Download Statistics

App

By:

Jacob Beniflah, MD

Rating:

2.90

(27)

Version:

2.8 Last updated: 2014-11-10

Version code:

837158397

Creation date:

2011-04-25

Compatible devices:

Size:

1.95MB

Price:

1.99

Full description:

Source:

Apple Apps Store

Data ingested on:

2026-06-11

Compare stats and ranking:

Ranking

# 302,163 ▼ 1,255

For Developers

Monetize with App Pass Boost with Extension Booster

Contact the developer

Chrome-Stats does not own this Apple app. Please use these information below to contact the Apple app developer.

Developed by:

Jacob Beniflah, MD

Apple Apps Store

https://apps.apple.com/us/app/bilicalc/id432749899

User Reviews

Users praise BiliCalc for its ease of use, intuitive inputs, and live nomogram plotting, making it a handy quick-reference in newborn care. Many consider it essential and valuable, especially for NICU and nursery work. However, a dominant issue is that the app remains outdated, aligned with 2004 guidelines and seemingly abandoned, with no clear update timeline for 2022 AAP guidelines. Reported risks include intermittent plotting inaccuracies and compatibility problems on older devices. Some users also note inconsistencies with other tools. Without updates, trust and reliability are questioned despite its potential usefulness.

Pros

Easy to use with a clean, intuitive interface and flexible input options (age or birth time)
Live plotting on the nomogram with clear graphical representations
Very useful in newborn care settings (nursery, NICU, pediatrics) as a quick reference
Strong perceived value and usefulness (often described as essential or best $2 spent)
Claims to be evidence-based and aligned with AAP recommendations

Cons

Not updated to the 2022 AAP guidelines; appears abandoned by the developer
Intermittent plotting/calculation inaccuracies that can be dangerous if not cross-checked
Compatibility issues on older devices/OS versions (e.g., iOS 11)
Differences or inconsistencies with other tools like BiliTool.org in some cases
No active updates or progress notices, leaving users uncertain about future support

Recent reviews

It’s a great app and easy to use but needs to be updated to the 2022 guidelines.

by Ag*****, 2024-10-25

The app still uses the old 2004 AAP guidelines and has not been updated to the 2022 guidelines. It appears to be effectively abandoned by the owner. There are other alternatives on the App Store. Is the app still functional? Yes… but it is no longer pertinent